<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>MYC oncogene &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/myc-oncogene/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 06 Sep 2025 09:34:34 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>MYC oncogene &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>FAM111B Knockdown Suppresses Ovarian Cancer by Downregulating MYC</title>
		<link>https://bioengineer.org/fam111b-knockdown-suppresses-ovarian-cancer-by-downregulating-myc/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 09 Aug 2025 03:00:43 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[cancer cell proliferation]]></category>
		<category><![CDATA[FAM111B gene]]></category>
		<category><![CDATA[MYC oncogene]]></category>
		<category><![CDATA[ovarian cancer therapy]]></category>
		<category><![CDATA[tumorigenesis suppression]]></category>
		<guid isPermaLink="false">https://bioengineer.org/fam111b-knockdown-suppresses-ovarian-cancer-by-downregulating-myc/</guid>

					<description><![CDATA[In a groundbreaking study published in BMC Cancer, researchers have unveiled a pivotal molecular mechanism that could reshape therapeutic approaches to ovarian cancer—a disease notoriously challenging both in diagnosis and treatment due to its aggressive nature and high mortality rate. The study zeroes in on FAM111B, a gene whose functional role in ovarian cancer has [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">254816</post-id>	</item>
		<item>
		<title>Unveiling the Hidden DNA Circles Driving the Aggressiveness of Pancreatic Cancer</title>
		<link>https://bioengineer.org/unveiling-the-hidden-dna-circles-driving-the-aggressiveness-of-pancreatic-cancer/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 12 Mar 2025 16:23:10 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[extrachromosomal DNA]]></category>
		<category><![CDATA[MYC oncogene]]></category>
		<category><![CDATA[pancreatic cancer]]></category>
		<category><![CDATA[therapy resistance]]></category>
		<category><![CDATA[tumor heterogeneity]]></category>
		<guid isPermaLink="false">https://bioengineer.org/unveiling-the-hidden-dna-circles-driving-the-aggressiveness-of-pancreatic-cancer/</guid>

					<description><![CDATA[Researchers at the University of Verona, in collaboration with the University of Glasgow and the Botton-Champalimaud Pancreatic Cancer Centre, are shedding light on an astonishing factor in pancreatic cancer that may revolutionize how we understand and treat this lethal disease. The study, which has recently garnered attention, highlights the significant role of extrachromosomal DNA (ecDNA) [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">238209</post-id>	</item>
	</channel>
</rss>
